The Dr family of related adherence structures, some fimbriated and others afimbriated, bind to decayaccelerating factor molecules on human cells. Dr is associated with recurring urinary tract infection (UTI), but the distribution of Dr subtypes among uropathogenic Escherichia coli causing UTI among otherwise healthy women has yet to be described. A total of 787 UTI and fecal E. coli isolates from college women were screened for the presence of Dr sequences (drb). Fifteen percent of UTI strains were drb positive, compared to 5% of fecal strains. The adhesin (E gene) subtype of each drb-positive strain was determined by type-specific PCR followed by restriction enzyme analysis. Among 78 drb-positive strains, we found 14 (18%) afaE1, 1 (1.3%) afaE2, 1 (1.3%) afaE3, 9 (12%) draE, 9 (12%) draE-afaE3 hybrid, 1 (1.3%) daaE, 32 (41%) afaE5, 4 (5.1%) F131 E gene-like, and 7 untypeable strains. All untypeable E genes were cloned and sequenced, revealing four additional new classes of E genes, including two similar to the previously identified nonfimbrial E series. While a great range of diversity exists among the E genes, restriction fragment length polymorphism analysis demonstrated that all of these drb operons share a highly conserved gene structure. The most common subtype, afaE5, occurred three times as often among UTI than fecal strains. Over half of the drb-positive strains and 80% of those positive for afaE5 have the same virulence signature (positive for aer, kpsMT, ompT, and fim), suggesting an association of this profile with UTI pathogenesis.
Bacterial adherence to host cells is a crucial step in the initiation of various infectious diseases (9, 24 ). An array of adhesins including type 1, P, S, and G fimbriae as well as adhesins of the Dr family and nonfimbrial adhesins (NFAs) have been identified in Escherichia coli strains causing urinary tract infection (UTI) (17, 19, 22) . Adherence factors facilitate the colonization of the urinary tract and promote E. coli colonization and persistence in the colon or vagina, which may serve as a reservoir for ascending infection in the urinary tract (10, 22) . The variety of adhesins, as well as the antigenic diversity of certain adhesins, may extend bacterial tissue tropism to different sites, facilitating the multiple stages of the pathogenic process.
Several pieces of evidence suggest that Dr adhesins play an important role in UTI pathogenesis. Dr adhesins occur more frequently among E. coli UTI isolates than fecal isolates (10, 22) , and the presence of Dr at the time of a first UTI has been associated with an increased risk of a second UTI (13) . Dr receptors, the Dr blood group antigen component of decayaccelerating factor (31, 32) , are widely distributed along the urinary tract, underlining the potential importance of Dr adhesin-producing E. coli in ascending colonization of the urinary tract. Furthermore, a pathogenicity study using a mouse model demonstrated that a Dr hemagglutinin-positive E. coli strain was much more virulent in terms of causing persistent and severe UTI than its isogenic mutant (10, 18) .
Structural and assembly genes required to produce adhesins of the Dr family are present in operons, each consisting of at least five genes often named A to E (a representative afa-1 operon is shown in Fig. 1 ) (26) . This fimbrial gene organization is quite different from that for other operons such as type 1 and P-pilus operons but are similar to that reported for the adhesin gene cluster of enteroaggregative E. coli (34) . Other potential regulatory genes located upstream of gene A have been identified in some adhesin-encoding gene clusters (5, 16) . In all but the dra operon (coding for Dr hemagglutinin), genes A to D encoding mostly accessory functions among the family are very similar in terms of amino acid sequence homology and functional homology. The last gene in each operon, E, encodes a protein that functions both as the major structural protein and as an adhesin molecule. Most of the sequence heterogeneity between family members occurs in the E gene. Similar genes exist in the dra operon, but the dra genes were named in reverse alphabetical order compared to their counterparts in other operons; thus, draA encodes the adhesin/structural protein (33) . Recently, Carnoy and Moseley (7b) renamed the dra genes to fit the order found in the afa genes. In this report, we are also following this latter naming system shared by the majority of drb operons, in which E is the last gene in each operon.
Dr hemagglutinin, F1845, AfaE-I, and AfaE-III, have been studied in detail. Despite the similarities among them, interesting differences exist. Dr hemagglutinin, F1845, AfaE-I, and AfaE-III each bind to functionally distinct sites on decay-accelerating factor (32) . Dr hemagglutinin and F1845 have fimbrial structures, while AfaE-I and AfaE-III are afimbrial. While Dr hemagglutinin and AfaE-III differ in only three amino acids, they differ in fimbriation, and Dr hemagglutinin recognizes type IV collagen as an additional receptor and is chloramphenicol sensitive; AfaE-III is not (38) . The phenotypic differences among adhesin subtypes of the Dr family are probably due to sequence differences in their E genes (15, 28, 36) . The differences in chloramphenicol sensitivity for hemagglutination between AfaE-III and Dr hemagglutinin were first shown to reside in the N-terminal 54 amino acids (36) and then specifically localized to the presence of an asparagine residue and an aspartic acid residue at position 52, respectively (28) . Other hybrid experiments have demonstrated that the N-terminal regions are critical for determination of fimbrial status (15) . The existence of other adhesin variants such as AfaE-II and the newly discovered AfaE-V (14) and F131 (30) suggests even greater sequence heterogeneity in the genetic determinant encoding the structural adhesins of the Dr family.
Most previous studies describing the prevalence of drb among UTI isolates have used probes that cross-react with all members of the Dr family. Thus, the relative distribution of each subtype is unknown. Furthermore, many previous studies have had relatively small sample sizes and screened UTI isolates from laboratory collections rather than from defined populations (3, 8) . In this study, we describe the frequency of the drb gene cluster and adhesin subtypes in a large collection of E. coli isolates from a well-defined population sample representative of otherwise healthy young women with first-time UTI and compare them with that of a fecal collection from healthy women of the same age group. We do similar comparisons with smaller collections of E. coli isolates from second UTI and from recurrent UTI (RUTI). We also describe the antigenic diversity of adhesin-encoding genes within this population and four new adhesin subtypes. The co-occurrence of drb genes with other virulence factors is also investigated, and virulence profiles of drb-positive strains are presented.
MATERIALS AND METHODS
Sample collection. We used E. coli isolates from three different collections. Urinary E. coli isolates were collected from a cohort of 304 women 18 to 40 years of age with a first UTI followed up for recurrence during the next 6 months. A total of 315 first UTI isolates and 49 second UTI isolates were collected at the University of Michigan Health Service and the University of Texas at Austin Health Service during 1992 to 1995. Twenty-eight E. coli isolates were collected during fall of 1994 from 27 UTI patients who had a history of RUTI, defined as at least two episodes of UTI in the prior year. Women clinically diagnosed with pyelonephritis were excluded from all UTI collections. A detailed description of recruitment methods and sociodemographic characteristics of part of the cohort are presented elsewhere (13) . All urinary isolates were collected and processed as described previously (12) . A total of 395 fecal E. coli isolates were collected from 318 consecutively sampled college women using the gynecology clinic at the University of Michigan Health Service during February and March 1996. Fecal isolates were collected using the Cultureswab Transport System (Difco Laboratories, Detroit, Mich.) and streaked for isolation on both Trypticase-soy agar with 5% sheep blood and MacConkey agar. Any phenotypically different colonies were identified and processed by using the same procedures as used for urinary E. coli (12) .
Bacterial strains, plasmids, and culture conditions. Strain TOP10FЈ (Invitrogen, San Diego, Calif.) was used as the host strain for recombinant plasmids. The following E. coli strains were used as controls for DNA hybridization and PCR studies: C248 (AfaE- were from the collection of one of us (C. Le Bouguenec). Plasmid pZErO-1 (Invitrogen) was used as the cloning vector. Plasmid pIL14 (provided by A. Labigne-Roussel, Institut Pasteur, Paris, France), containing the afa-1 operon, was used as the source for DNA probes. All clinical and control strains were grown in Luria-Bertani (LB) broth or on LB plates at 37°C. E. coli HB101 carrying plasmid pIL14 was grown in LB broth or on LB plates with ampicillin (100 g/ml). Low-salt LB agar plates with isopropylthio-␤-D-galactoside (50 g/ml) and Zeocin (50 g/ml) were used for the selection of transformants as instructed by the manufacturer (Invitrogen).
Hemagglutination. We used the method of Nowicki et al. (32) for hemagglutinations. Briefly, normal human group O erythrocytes were washed in phosphate-buffered saline (138 mM NaCl 2 , 1 mM NaH 2 PO 4 , 8 mM Na 2 HPO 4 ) and resuspended to 3% (vol/vol) in phosphate-buffered saline with 2.5% ␣-methyl-D-mannoside. Hemagglutination was performed in microtiter plate wells at room temperature and at 4°C by mixing equal volumes (40 l) of serial twofold bacterial dilutions and erythrocyte suspensions. Inhibition of mannose-resistant hemagglutination (MRHA) by chloramphenicol was tested by the addition of 10 M chloramphenicol to an identical erythrocyte suspension prior to the assay for hemagglutination.
DNA isolation and DNA probes. Plasmid DNAs used for enzymatic manipulation were routinely prepared by an alkaline lysis procedure (21) and by using a plasmid preparation kit (Qiagen, Chatsworth, Calif.). Routine plasmid screening was done by the rapid lysis method of Kado and Liu (23) . Larger amounts of purified total DNA were prepared by the methods of Hull et al. (20) . DNA fragments containing afa-1 were isolated by restriction endonuclease digestion of pIL14 plasmid DNA followed by gel electrophoresis. Either a 2.6-kb PstI fragment or three PstI fragments (2.6, 1.1, and 0.4 kb) were cut out, and the DNA was eluted. The purified DNA fragments were used as templates to generate digoxigenin-labeled DNA probes (Genius System kit; Boehringer Mannheim, Indianapolis, Ind.). Dot and Southern blots. We screened for virulence factors by using dot blot hybridization as previously described (12) . Both dot blots and Southern blots were hybridized to digoxigenin-labeled DNA probes, using conditions described previously (12) .
Subtyping by PCR and restriction digestion. The subtype of each drb-positive strain was determined by PCR using a conserved primer derived from a common 5Ј flanking region and a selective primer derived from the unique coding region within each known subunit gene. Table 1 lists the oligonucleotide primers used in PCR subtyping. Full-length adhesin-encoding genes of four Dr subtypes, AfaE-III, Dr hemagglutinin, AfaE-V, and F131, were amplified by a pair of primers (conserved primer and degenerate primer in Table 1 ). Amplification reactions were carried out with a MicroCycler (Eppendorf Inc., Fremont, Calif.). To differentiate between AfaE-III and Dr hemagglutinin, restriction patterns were compared by digestion of PCR products with enzymes Tsp92I and Hsp509I. To differentiate between AfaE-V and F131, restriction patterns were compared by digestion of PCR products with enzymes BamHI and AvaII. a Distance of PCR fragment generated by using the conserved primer plus each addition primer. b The nucleotide sequence accession number for afaE2 is X85782. c The nucleotide sequence accession number for afaE5 is X91748.
Cloning and sequencing. Two approaches were used for cloning E genes of the new subtypes. A conserved primer and a degenerative primer (Table 1) were used in PCR to amplify E gene sequences from strains with untypeable subtypes. The amplified DNA was cloned into plasmid vector pZErO-1. Two independent recombinant molecules constructed from the insertion of each PCR product were selected. Alternatively, DNA from these strains was isolated and digested with SmaI, and the appropriate DNA fragment was identified by Southern hybridization with the DNA probe A ( Fig. 1) and eluted from the gel after agarose gel electrophoresis. The DNA fragments were then purified and cloned into the plasmid vector. The recombinant plasmid DNAs were prepared by using a plasmid kit (Qiagen). The sequence of the double-stranded DNA was determined at the University of Michigan Molecular Biology Core Facility by an Applied Biosystems model 373A automated sequencer. When required, new internal oligonucleotide primers were synthesized on the basis of the determined sequence and used as new sequence primers. GenBank accession numbers for these sequences are U87540 and U87790.
Other genetic methods. Restriction enzyme digestion, nuclease treatment, and ligation were performed by standard procedures according to the methods of Maniatis et al. (29) and the manufacturers' instructions. Transformation was accomplished by calcium chloride preparation of competent cells. DNA was recovered from agarose gels by using an Elu-Quick DNA purification kit (Schleicher & Schuell, Keene, N.H.). PCR-amplified DNA was purified by using by a QIAquick Spin PCR purification kit (Qiagen). The afaD genes were amplified by PCR using a pair of primers (5Ј-CTGAGCTCCACCTGGAGAGC-3Ј; 5Ј-TTC CTGTGGCACCACACAGG-3Ј) derived from afaD3 internal sequences (15) .
Data analysis. Differences between groups were tested by using 2 , a test for equality of two proportions, or, for smaller sample sizes, the Fisher exact test. Excel software (Microsoft, Redmond, Wash.) was used for data entry. Software packages from DNAStar (Madison, Wis.) were used for DNA sequence and amino acid sequence analysis and comparison. For amino acid comparisons, a Lipman-Pearson protein alignment (Ktuple ϭ 2; gap penalty ϭ 4; gap length penalty ϭ 12) was initially used to align the pilin proteins. The number of perfect matches divided by the length of the longest pilin times 100 was defined as percent identical, while the number of perfect matches plus the number of conservative amino acid substitutions divided by the length of the longest pilin times 100 was defined as percent similar.
RESULTS
Detection of drb sequences among E. coli isolates. A total of 787 E. coli strains from otherwise healthy college women with a first UTI, a second UTI, or RUTI and from fecal specimens of college women without UTI were screened by dot blot hybridization for the presence of a sequence homologous to that of drb with a conserved DNA probe derived from the afa-1 operon (probe A in Fig. 1 ). Strains positive by dot blot hybridization were confirmed by Southern hybridization using the same probe. Sequence homology to drb was found in 49 of the 315 first UTI strains (16%), 7 of the 49 second UTI strains (14%), 2 of the 28 RUTI strains (7.1%), and 20 of the 395 fecal strains (5%); 3.6% of the 166 fecal strains from women with previous UTI history and 6.1% of the 229 fecal strains from women without a UTI history were drb positive (P Ͻ 0.001). Hybridization with the drb gene probe was 3.5 (odds ratio) (95% confidence interval, 2.0 to 5.9) times more common among E. coli isolates from patients with first cystitis than from control fecal isolates.
Adhesin subtype classification. Because of the homology between the adhesin subtypes, DNA hybridization cannot distinguish one subtype from another. We used PCR to differentiate between subtypes for each drb-positive E. coli isolate. Each known subtype was identified by PCR using a pair of primers: a conserved primer derived from the sequence immediately upstream of the adhesin-encoding gene that was conserved among all subtypes, and type primers derived from various regions of the E gene sequence where each given subtype had a sequence uniquely different from those of all other subtypes (Table 1) . However, there were two exceptions: since afaE3 and draE are 99.4% identical, and afaE5 and f131E are 97% identical, at the DNA level, the same type primer was used within each pair. AfaE-III and Dr, and AfaE-V and F131, were thus classified into the same groups by PCR. We confirmed that the correct subtype was amplified in each PCR by showing the different-size PCR fragments were produced by the different types of primers (353 to 487 bp [ Table 1 ]), a result verified by agarose gel electrophoresis (Fig. 2) .
Discovery of afaE3-draE and draE-afaE3 hybrids. To differentiate between AfaE-III and Dr hemagglutinin as well as between AfaE-V and F131, we used the minor changes in endonuclease restriction sites caused by the difference between the respective pairs of sequences. A 534-bp DNA fragment containing the entire E gene from all four subtypes was PCR amplified. Of the PCR-amplified DNA fragments, AfaE-V was distinct from F131 by a BamHI restriction site (none in AfaE-V and one in F131) and by AvaII restriction sites (two in AfaE-V and one in F131). AfaE-III was distinct from Dr hemagglutinin by Tsp509I restriction sites (one in AfaE-III and two in Dr hemagglutinin) and by a Hsp92I restriction site (none in AfaE-III and one in Dr hemagglutinin). By the restriction pattern, the F131-AfaE-V group could be clearly broken down into two expected subtypes: 4 F131 types and 32 AfaE-V types. This was not true for the AfaE-III-Dr hemagglutinin group; of 19 strains, 1 and 9 could be classified as AfaE-III and Dr, respectively, by both restriction sites. Eight strains were Dr by Tsp509I restriction pattern but AfaE-III by Hsp92I restriction pattern (afaE3-draE hybrids). One was AfaE-III by Tsp509I restriction pattern but Dr by Hsp92I restriction pattern (draEafaE3 hybrid).
One representative strain from each of the afaE3-draE and draE-afaE3 hybrid groups was chosen for sequence analysis. The three nucleotides that differentiate afaE3 and draE are at positions ϩ217 (an A in afaE3 or a G in draE), ϩ326 (T or C, respectively), and ϩ395 (C or T, respectively). The sequenced afaE3-draE hybrid had the nucleotides A, C, and T at these three sites and also had one nucleotide different from either afaE3 or draE at position ϩ22. This difference is predicted to change one amino acid in the signal sequence from Ala to Thr. The sequenced draE-afaE3 hybrid had two silent changes at positions ϩ24 and ϩ411. Since position ϩ217 (amino acid 52 in the mature adhesin) has been shown to be critical for both fimbriation and receptor binding characteristics (15), we predicted that afaE3-draE hybrids would be phenotypically AfaE-III-like and that the draE-afaE3 hybrid would be phenotypically Dr-like. A hemagglutination assay (see Materials and Methods) was used to test for inhibition of MRHA by chloramphenicol. As predicted, the four hemagglutination-positive afaE3-draE hybrids were resistant to inhibition by chloramphenicol (similar to afaE3-positive strains), while the draEafaE3 hybrid had its hemagglutination inhibited by chloramphenicol (similar to draE-positive strains). Subtype distribution by strain source. Every known Dr adhesin subtype was found in our urinary E. coli collection, but the subtypes occurred at different frequencies. Among the drb-positive UTI strains, 41% were AfaE-V, 18% were the AfaE-I subtype, 13% were Dr-like (nine draE plus one draEafaE3 hybrid), 12% were AfaE-III-like (one afaE3 plus eight afaE3-draE hybrids), 5% were F131, 1% were AfaE-II, and 1% were the F1845 subtype. While the predominant subtypes were the same in both UTI and fecal isolates, the relative frequencies were very different ( Table 2 ). Every subtype was found more frequently among urinary than fecal isolates. The most common subtype, AfaE-V, was over three times more frequent in first UTI than fecal isolates (P ϭ 0.01), as were the Dr-like subtypes (P ϭ 0.03).
Cloning and sequencing of new adhesin-encoding genes. Seven of the 78 total drb probe-positive strains (four UTI strains and three fecal strains) could not be classified as any known subtype by PCR. These strains could represent additional adhesin variants or deletions in the gene clusters. To address this question, we used both PCR cloning and genomic cloning to identify potential DNA segments that carry alternative or deleted E genes. The cloned DNA segments were sequenced to identify the relatedness to known Dr subtypes.
All known subtypes have a conserved DNA sequence immediately upstream of the E gene and share two conserved amino acids at the C-terminal end. Thus, we hypothesized that additional adhesin variants could have similar sequence conservation. A pair of primers was used to amplify the full length of the E gene region in the seven strains with a possible new adhesin subtype: the same conserved primer used in PCR typing and a downstream degenerate primer (Table 1) including all DNA sequences which could encode the conserved C-terminal amino acids and stop codon. Various amplification conditions were tried, and a DNA fragment with the expected size (ϳ580 bp) was obtained from four of the seven strains. These DNA fragments were cloned and sequenced. Sequence results identified two new classes of E genes, drb121 and drb122. The drb121 gene gives a predicted amino acid sequence for Dr121 that matches most closely that of F1845 (48% identical, 69% similar), while drb122 gives a predicted amino acid sequence for Dr122 that matches most closely those of F131 and AfaE-V (78% identical, 88% similar).
The remaining three isolates did not produce a band by PCR. Based on Southern hybridization and PCR analysis, these three strains differ in the 5Ј flanking regions; thus, the conserved primer does not work in these three strains (data not shown). We then used genomic cloning to isolate the E gene from the three remaining strains. Total DNA was digested with SmaI. DNA fragments of about 3 and 3.5 kb, which should include the E gene region, were identified by Southern hybridization using an ϳ200-bp DNA probe that hybridized to sequences downstream of the SmaI site (Fig. 1) . DNA fragments were purified from the agarose gel and cloned into the plasmid vector pZErO-1. Upon sequencing the cloned fragments, we identified two additional classes of E genes, which we named nfa111 and nfa116. While Drb121 and Drb122 appear to belong to the previously defined Dr family, NFA111 and NFA116 have no amino acid sequence similarity with any Dr adhesin subtype. NFA111 and NFA116 do have sequences similar to the NFA series (Table 3) . Although NFAs have not previously been considered part of the Dr family, they are very similar in genetic organization (1, 16) . Since these NFA series can be detected by the same drb probe and have upstream flanking sequences similar to those of the Dr family (Fig. 3) , they may well belong to the same group. However, it remains to be shown that they bind to decay-accelerating factor.
Genetic comparison of various adhesin carrying operons.
Genetic conservation has been demonstrated with a common 4.1-kb internal fragment shared by all afa-related members (25) . Here we extend the comparison to all E gene classes, including our four newly identified ones. We compared restriction fragment length polymorphism (RFLP) patterns among all adhesin classes by Southern hybridization using the accessory gene probe (probe B in Fig. 1 , with a 4.1-kb DNA fragment composed of three PstI fragments [2.6, 1.1, and 0.4 kb] from the afa-1 operon) and the E gene probe (three PCRamplified DNA fragments in Fig. 2, lanes 2, 4, and 6 ). All drb subtypes including the NFA series share a very conserved 4.1-kb (three PstI fragments [2.6, 1.1, and 0.4 kb]) segment (Fig. 4) , while E genes and their 3Ј flanking regions are highly variable (Fig. 5) .
It has been suggested that afaD3 is the second adhesin gene in the afa-3 operon (15). To determine if this sequence was also conserved among the D genes in other subtypes, we used PCR analysis with a pair of primers internal to the afaD3 gene.
The D gene sequence appears to be conserved in most drb subtypes strains tested (Fig. 6 ). NFA111 shows no PCR fragment, and Drb122 shows a PCR fragment with smaller size.
Virulence profiles of strains producing Dr family adhesins. All of our E. coli isolates were screened by DNA hybridization for the presence of nine virulence factors: type I (fim), Pap and Prs pili (prf), S fimbria (sfa), aerobactin (aer), group II capsule (kpsMT), outer membrane protease T (ompT), ␣-hemolysin (hly), cytotoxic necrotizing factor 1 (cnf1), and adhesins of the Dr family (drb) as previously described (12) . This genotyping generated a virulence signature for each strain based on the presence or absence of these nine virulence factors. Most of the drb-positive strains were also positive for aer (83%). Only one strain in our collection that was drb positive was positive for the toxin hly or cnf1. The Dr adhesins occurred only rarely with other MRHA adhesins such as S fimbria and P pili: 99 and 80% of drb-positive strains were negative for sfa and prf, respectively. Of greatest interest, half (51.3%) of the drb-positive strains belonged to a single virulence signature: 100111001 (Table 4) , positive for fim, aer, kpsMT, ompT, and drb and lacking the other genes tested. This virulence signature was present in 7.6% of first UTI isolates, 8.2% of second UTI isolates, and 2.8% of fecal isolates. We carried out RFLP analysis using variation in the fim locus on the 25 isolates with the most common virulence signature and the afaE5 gene. Figure 7 shows the hybridization patterns seen for seven strains with this predominant pattern, plus two strains with a second pattern and a third with yet a different pattern. In total, four (Table 1) Chromosomal and plasmid location of drb genes. The presence of the Dr family of adhesins is highly correlated with the presence of aerobactin (encoded by aer). Since aer can also be plasmid borne, the correlation might be caused by physical linkage. To address this question, the locations of both drb and aer determinants among drb-positive strains were analyzed by Southern hybridization using DNA probes (Fig. 8) . Only 12% of the drb genes were found on large plasmids; all of the remaining drb genes were located on the chromosome. By subtype, 30% of draE, 16% of afaE5, 11% of afaE3, and 0% of all other subtypes were found on plasmids. Of the 65 drbpositive strains that were also positive for aer, at most five (6%) had both genes on the same plasmid. Thus, the correlation between drb and aer genes can be only partially explained by colocalization on a plasmid.
DISCUSSION
Previous studies have failed to agree on the frequencies of drb in UTI and fecal E. coli isolates (2, 3, 8, 25, 33, 35) . Several studies have small sample sizes and/or variable or poorly defined study groups probably contributing to the discrepancies. Frequencies may also differ by age, geographic location, or disease severity. Data pooled across several studies suggests that Dr family adhesins occur twice as frequently among UTI compared to fecal isolates (10) . We observed a threefold difference in sequences homologous to drb when we compared the frequency among 315 first-time UTI isolates from otherwise healthy college women to the frequency among 395 fecal isolates from healthy college women without UTI (15% versus 5%). This finding strongly supports an association between drb and first-time UTI in otherwise healthy young women. AfaE-V was the most common subtype in each E. coli collection but occurred proportionally more frequently in first-time UTI than fecal isolates, suggesting a possible specific role in adherence to the bladder.
In subtyping our collection of E. coli strains, we discovered genes with a sequence intermediate between the sequence found in subtypes afaE3 and draE. These intermediate strains were discovered when restriction enzyme analysis of the PCR products revealed that only 10 of 19 strains amplified with the subtype AfaE-III/Dr-type primer (Table 1) gave PCR products which corresponded to either afaE3 or draE sequences. Eight products appear to be a hybrid containing the N-terminal half of afaE3 and the C-terminal half of draE. One product is the opposite hybrid: it contains the N-terminal half of draE and the C-terminal half of afaE3. N-terminal regions are critical for the differences seen between AfaE-III and Dr relative to fimbrial status (15) and chloramphenicol sensitivity for hemagglutination (28, 36) . Thus, our eight afaE3-draE hybrids should be phenotypically similar to AfaE-III in being nonfimbriated and chloramphenicol resistant, while the draE-afaE3 hybrid should behave like Dr in being fimbriated and chloramphenicol sensitive. Since the phenotypic differences are the ones that we expect to play a role in any pathogenic differences, we did our distribution analysis with the afaE3-draE hybrids listed as AfaE-III-like and the draE-afa3 hybrid listed as Dr-like in Tables 2 and 4 .
The drb sequences in our E. coli collection included the whole spectrum of Dr subtypes previously identified as well as our four completely new ones, for a total of at least 10 E gene subtypes (depending on how drbE genes with intermediate sequence between afaE3 and draE are categorized). Despite significant sequence differences among E genes, all previously identified Dr subtypes and as well as our newly identified Dr subtypes (including NFA-like sequences) share highly conserved genes within the same gene cluster. They have the same DNA PstI fragment of about 4.1 kb which has been demonstrated among afa operons (25) . The ϳ150-bp segments between PstI (p1 to p3 in Fig. 1 ) and the beginning of the E gene are almost identical among the classical Dr subtypes. Recent studies suggest that afaD3 of the afa-3 gene cluster may act as a second adhesin molecule (15) . We found the D gene to be highly conserved. Over half of the drb-positive strains in our collection had the same virulence signature: 100111001, which is positive for fim, aer, kpsMT, ompT, and drb and negative for prf, sfa, hly, and cnf1 (Table 4 ). This virulence signature group accounted for 78% of the most common Dr subtype, AfaE-V, 80% of the Dr-like strains, and 75% of the F131 strains. Whether virulence signature 100111001 corresponds to serotype O75, which has been associated with the Dr family of adhesins (33, 39) , is unknown.
There are at least three possible explanations for the observed association of the Dr adhesin with a set of virulence genes: (i) physical co-localization, (ii) clonality, and (3) codependence in particular pathogenic disease pathways. Pathogenicity islands containing multiple virulence factors such as P pili, hemolysin, and CNF1 found in some uropathogenic E. coli isolates (7, 37) are a prime example of physical colocalization. fim, kpsMT, ompT, and, when on the chromosome, aer and drb map to different chromosomal locations. Further, only 9% of drb genes in our strains are on plasmids, and only half of those plasmids also contain aer. Therefore colocalization of the genes does not seem to be a plausible explanation of the association of drb with this particular virulence signature.
If a single clone were responsible for a significant proportion of UTIs caused by Dr-adherent strains, then the copresence of the other virulence genes might be a chance occurrence. However, the majority of isolates from three different drb subtypes have the same virulence signature. RFLP analysis using variation in the fim locus showed that 20 of 25 isolates with the most common virulence signature and the afaE5 gene fall into a single RFLP group. Therefore, half of the 40 strains with the predominant virulence signature are part of a single dominant clone, but the other half fit into at least eight other clonal types with no more than four members each, based on subtype and RFLP analysis.
Finally, codependence of these virulence factors in particular pathogenic disease pathways may explain the association of drb with a particular virulence signature. Our data support the possibility that strains with the 100111001 virulence signature use a particular pathogenic pathway to cause UTI. This pathway may differ from that used by UTI E. coli expressing P pili, hemolysin, and CNF1. Different pathogenic pathways may involve differences in mode of transmission. Epidemiologic studies exploring the latter possibility are ongoing.
Dr is associated with risk of a second UTI (13); thus, a better understanding of the role of Dr subtypes in pathogenesis is warranted. In a large population-based sample of UTI isolates, we found a particular Dr-associated virulence profile to predominate, suggesting an association of this profile with UTI pathogenesis. In between 20 and 30% of all women with a first UTI, the infection recurs within 6 months (11); recurrences account for the vast majority of UTIs treated annually. It will therefore be important to determine if the predominate Drassociated virulence profile found in this study is also present in significant numbers of strains from women with recurrences.
